 Parkinson Disease
"Parkinson Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Descriptor ID |
D010300
|
| MeSH Number(s) |
C10.228.140.079.862.500 C10.228.662.600.400 C10.574.812
|
| Concept/Terms |
Parkinson Disease- Parkinson Disease
- Idiopathic Parkinson's Disease
- Lewy Body Parkinson Disease
- Lewy Body Parkinson's Disease
- Primary Parkinsonism
- Parkinsonism, Primary
- Parkinson Disease, Idiopathic
- Parkinson's Disease
- Parkinson's Disease, Idiopathic
- Parkinson's Disease, Lewy Body
- Idiopathic Parkinson Disease
- Paralysis Agitans
|
Below are MeSH descriptors whose meaning is more general than "Parkinson Disease".
Below are MeSH descriptors whose meaning is more specific than "Parkinson Disease".
This graph shows the total number of publications written about "Parkinson Disease" by people in this website by year, and whether "Parkinson Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1997 | 2 | 0 | 2 | | 1998 | 2 | 0 | 2 | | 1999 | 0 | 1 | 1 | | 2000 | 5 | 1 | 6 | | 2001 | 4 | 1 | 5 | | 2002 | 4 | 2 | 6 | | 2003 | 6 | 0 | 6 | | 2004 | 3 | 1 | 4 | | 2005 | 3 | 2 | 5 | | 2006 | 0 | 1 | 1 | | 2007 | 9 | 1 | 10 | | 2008 | 8 | 1 | 9 | | 2009 | 6 | 2 | 8 | | 2010 | 2 | 1 | 3 | | 2011 | 14 | 2 | 16 | | 2012 | 10 | 1 | 11 | | 2013 | 10 | 1 | 11 | | 2014 | 14 | 2 | 16 | | 2015 | 13 | 1 | 14 | | 2016 | 17 | 1 | 18 | | 2017 | 35 | 0 | 35 | | 2018 | 20 | 2 | 22 | | 2019 | 21 | 3 | 24 | | 2020 | 26 | 4 | 30 | | 2021 | 19 | 1 | 20 | | 2022 | 23 | 1 | 24 | | 2023 | 34 | 0 | 34 | | 2024 | 24 | 1 | 25 | | 2025 | 17 | 0 | 17 | | 2026 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Parkinson Disease" by people in Profiles.
-
Yilmaz S, Aslam S, Sillau S, Katz M, Kluger B. Bridging the gap: Evaluating a community-based palliative care intervention for underserved patients with Parkinson's disease. Parkinsonism Relat Disord. 2026 May; 146:108262.
-
Nelson CA, Obray JD, Roll CR, Williams PE, Smith KJ, Harris WT, Hafen CW, Burris MD, Manwaring KH, Adams DN, Weber KS, Hope S, Mitchell UH, Yorgason JT, Steffensen SC. Leukocytic Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels in Parkinson Disease. Am J Pathol. 2026 05; 196(5):1188-1204.
-
Coughlin DG, Adler CH, Barbosa W, Feuerstein J, Galasko D, Gunzler SA, Jimenez-Shahed J, Kannarkat GT, Lang AE, Martinez-Lemus JD, LeWitt PA, Pantelyat A, Schiess MC, Schwarzschild M, Siderowf AD, Simuni T, Tropea TF, Thordarson D, Vila C, Adams JL, Rosenthal L. CSF a-Synuclein Seed Amplification Assays and Skin Immunofluorescence: Clinical Applications, Research Opportunities, and Knowledge Gaps. Neurology. 2026 Feb 10; 106(3):e214648.
-
Dang NH, Kern DS, Honce JM, Ojemann SG, Tanabe JL. Skull Lesions after MR-Guided High-Intensity Focused Ultrasound: A Case Series. AJNR Am J Neuroradiol. 2026 Jan 05; 47(1):126-130.
-
Hickman J, Tsai A, Fullard M, Korsmo M, Forbes E, Aslam S, Baumgartner AJ, Feuerstein JS, Bayram E. Early-Onset Parkinson's Disease: Unique Features and Management Approaches. Curr Neurol Neurosci Rep. 2025 Dec 18; 26(1):3.
-
Mañago MM, Van Valkenburgh L, Boncella K, Will R, Feuerstein J, Swink LA, Christiansen CL. Blood Flow Restriction Training in People With Parkinson Disease: A Mixed-Methods Feasibility Study. J Neurol Phys Ther. 2026 Jan 01; 50(1):2-11.
-
Starr PA, Shivacharan RS, Goldberg E, Tröster AI, House PA, Giroux ML, Hebb AO, Whiting DM, Leichliter TA, Ostrem JL, Metman LV, Sani S, Karl JA, Siddiqui MS, Tatter SB, Haq IU, Machado AG, Gostkowski M, Tagliati M, Mamelak AN, Okun MS, Foote KD, Moguel-Cobos G, Ponce FA, Pahwa R, Lyons K, Buetefisch CM, Gross RE, Luca CC, Jagid JR, Revuelta GJ, Takacs I, Pourfar MH, Mogilner AY, Duker AP, Mandybur GT, Rosenow JM, Zadikoff C, Khandhar SM, Sedrak M, Phibbs FT, Neimat J, Durphy J, Ramirez-Zamora A, Pilitsis JG, Uitti RJ, Wharen R, Park MC, Vitek JL. Five-Year Outcomes from Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson Disease. JAMA Neurol. 2025 Nov 01; 82(11):1181-1190.
-
Thompson JA, Radcliffe EM, Ojemann S, Kramer DR, David-Gerecht P, Case M, Zarns C, Holt-Becker A, Raike RS, Baumgartner AJ, Kern DS. Unipolar recordings of beta power inform initial programming of the subthalamic nucleus in Parkinson's disease. Parkinsonism Relat Disord. 2025 Dec; 141:108078.
-
Callisaya ML, Alty J, de Groot D, Lamotte G, Luthra N, McKee KE, Su EJ, Corcos DM. Advice to people with Parkinson's in my clinic: How to manage running-induced dystonia. J Parkinsons Dis. 2025 Dec; 15(8):1345-1352.
-
Martín-Bórnez M, Shar N, Nour MA, Murphy D, Elsayed I, Nanjundaswamy MS, Nwaokorie F, Olusanya A, Kuznetsov N, Bandres-Ciga S, Noyce AJ, Iwaki H, Jones L, Gómez-Garre P, Mir P, Periñán MT. Does COMT Play a Role in Parkinson's Disease Susceptibility across Diverse Ancestral Populations? Mov Disord. 2025 Dec; 40(12):2819-2824.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|